Abstract:Attempts to quantify the performance of dialysis therapy had started even before maintenance dialysis became widely available. Initial efforts in 1950s were centered around measuring the ability of a dialyzer to remove the solute mass, leading to coinage of the terms "clearance" and "dialysance". 1 The concept of adequacy, or the understanding that patient outcome was linked to performance of dialyzer, gathered pace in the 1970s on the basis of work by Babb and Scribner (square-meter hour hypothesis), Kopp (li… Show more
“…So the need for dialysis will increase over time. However, there is a lack of information about the number of dialysis patients in Uttarakhand state [4]. Caregivers often receive little attention, and the main focus has remained on the patients.…”
Introduction: There is a scarcity of literature about the burden of hemodialysis patients’ caregivers. Caregivers often receive little attention, and the primary focus is always on the patients. Frequent hospitalizations and factors associated with the disease can lead to depression and reduce the caregiver’s quality of life. Objective: The study aimed to determine the burden of caregivers of patients undergoing hemodialysis at a tertiary care hospital. Materials and Methods: This cross-sectional analytical study was conducted in a tertiary care hospital in northern India. A total of 110 caregivers who were providing care to their patients for more than 3 months were selected by purposive sampling method. The study data were collected by self-prepared demographic questionnaire to collect basic information regarding patients and caregivers, and the level of burden was assessed by a revised Zarit Burden Interview (ZBI) standardized on a 5-point scale. Descriptive and inferential (the Chi-square and Fisher exact test, 1-way ANOVA test) statistics were used for data analysis. Results: The mean±SD age of caregivers was 37±13 years. Nearly half of caregivers, 50 (45.46%), reported mild to moderately burdened, while 15 (13.63%) caregivers had moderate to severely burdened. The caregivers were mild to moderately burdened as the mean burden score was 25±12. There was no significant association between the levels of burden scores and selected sociodemographic variables of the participants. Conclusion: It was found that caregivers of hemodialysis patients experienced moderate burden while caring and being with the patient, which may alter their health and quality of life.
“…So the need for dialysis will increase over time. However, there is a lack of information about the number of dialysis patients in Uttarakhand state [4]. Caregivers often receive little attention, and the main focus has remained on the patients.…”
Introduction: There is a scarcity of literature about the burden of hemodialysis patients’ caregivers. Caregivers often receive little attention, and the primary focus is always on the patients. Frequent hospitalizations and factors associated with the disease can lead to depression and reduce the caregiver’s quality of life. Objective: The study aimed to determine the burden of caregivers of patients undergoing hemodialysis at a tertiary care hospital. Materials and Methods: This cross-sectional analytical study was conducted in a tertiary care hospital in northern India. A total of 110 caregivers who were providing care to their patients for more than 3 months were selected by purposive sampling method. The study data were collected by self-prepared demographic questionnaire to collect basic information regarding patients and caregivers, and the level of burden was assessed by a revised Zarit Burden Interview (ZBI) standardized on a 5-point scale. Descriptive and inferential (the Chi-square and Fisher exact test, 1-way ANOVA test) statistics were used for data analysis. Results: The mean±SD age of caregivers was 37±13 years. Nearly half of caregivers, 50 (45.46%), reported mild to moderately burdened, while 15 (13.63%) caregivers had moderate to severely burdened. The caregivers were mild to moderately burdened as the mean burden score was 25±12. There was no significant association between the levels of burden scores and selected sociodemographic variables of the participants. Conclusion: It was found that caregivers of hemodialysis patients experienced moderate burden while caring and being with the patient, which may alter their health and quality of life.
“…The incidence of frailty increases with age and can reach 21.5% among the elderly in China [ 14 ]. Dialysis adequacy refers to the removal of excess water and toxins from the patient's body through HD to reach a comfortable state [ 15 ]. In a domestic study involving 120 MHD patients, dialysis adequacy was tested, and it was found that MHD patients with more adequate dialysis (i.e., urea clearance index ≥1.2) had a lower probability of muscle content decline and were less prone to frailty [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, malnutrition and sarcopenia are common complications in MHD patients. Evidence has shown that MHD patients with hypoproteinemia are more susceptible to frailty, and the SA level is negatively correlated with the degree of frailty [ 15 ]. Another study holds that sarcopenia is the core mechanism of frailty, and GS, WS, and MAMC are important indexes to diagnose and evaluate sarcopenia [ 16 , 17 ].…”
Objective. To explore the clinical implications of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for diagnosing frailty in patients with maintenance hemodialysis (MHD) and their correlations with patient prognosis. Methods. A total of 185 patients with MHD admitted to the hemodialysis center of our hospital were selected, 72 of whom were diagnosed with frailty according to the Chinese version of Tilburg Frailty Indicator (TFI). The relevant data were collected, and the influencing factors of frailty in MHD patients were analyzed by one-way analysis of variance (ANOVA) and multivariate logistic regression. The value of NLR and PLR in diagnosing frailty in MHD patients was observed, and patients’ all-cause mortality was compared during the 3-year follow-up. The influences of different levels of NLR and PLR on the survival of MHD patients were investigated. Results. Multivariate regression analysis identified that serum albumin, dialysis adequacy, NLR, and PLR are independent risk factors for frailty in MHD patients (
P
<
0.05
). The area under the receiver operating characteristic (ROC) curve of NLR and PLR in diagnosing frailty in MHD patients was 0.859 and 0.799, respectively. Compared with the nonfrailty group, the 3-year mortality was higher, and the 3-year survival rate assessed by survival analysis was lower in the frailty group (
P
<
0.05
). Patients with high NLR and PLR levels showed a lower 3-year survival rate. Conclusions. Dialysis adequacy, serum albumin, NLR, and PLR are independently associated with frailty in MHD patients. NLR and PLR are of a certain diagnostic value for frailty in MHD patients. MHD patients with frailty have an unfavorable prognosis, as of those with high NLR and PLR levels.
“… 1 The efficacy of HD is closely associated with patient survival time and quality of life. 2 , 3 The urea clearance index (Kt/V, where K = dialyzer clearance of urea, t = dialysis time, and V = volume of distribution of urea) and urea reduction rate (URR) are the 2 most important indices for evaluating the adequacy of dialysis. 3 , 4 These calculations are based on blood urea nitrogen (BUN) concentrations taken before and after dialysis.…”
Section: Introductionmentioning
confidence: 99%
“… 2 , 3 The urea clearance index (Kt/V, where K = dialyzer clearance of urea, t = dialysis time, and V = volume of distribution of urea) and urea reduction rate (URR) are the 2 most important indices for evaluating the adequacy of dialysis. 3 , 4 These calculations are based on blood urea nitrogen (BUN) concentrations taken before and after dialysis. The classical method (CLM) of obtaining these values, based on the second-generation Daugirdas formula, 5 , 6 is the most widely used method in clinical practice.…”
Background
The efficacy of hemodialysis (HD) is closely associated with patient survival time and quality of life. The classical method (CLM) to calculate the urea clearance index (Kt/V) and urea reduction rate (URR) requires multiple blood tests. A novel method that may be used as a noninvasive alternative to CLM is required.
Methods
Based on the urea kinetic model, a new method, named the “assessment method” (ASM), was established to calculate blood urea nitrogen after HD, based on parameters obtained during HD. The consistency of the Kt/V and URR values between the ASM and CLM was evaluated in 41 patients from the China–Japan Friendship Hospital between September 2017 and December 2018.
Results
Forty-one patients (24 males and 17 females; mean age, 55.7 ± 14.2 years) undergoing regular HD in our hospital were randomly selected for this study. The blood flow rate was 244.5 ± 19.6 mL/min and the dialysate flow rate was 500 mL/min. We obtained Kt/V (CLM = 1.40 ± 0.06, ASM = 1.37 ± 0.07) and URR (CLM = 68.6 ± 6.4%, ASM = 67.7 ± 7.2%) values. Paired
t
-test indicated no significant differences between the ASM- and CLM-derived values. The intraclass correlation coefficients were 0.907 and 0.916 for Kt/V and URR, respectively. Similarly, Bland–Altman plots suggested good concordance between the 2 methods.
Conclusions
The Kt/V and URR values calculated using the ASM and CLM were in significant agreement, and both can be used to effectively assess the adequacy of HD in patients undergoing maintenance HD. The ASM is an effective, rapid, inexpensive, and noninvasive alternative to the CLM for obtaining Kt/V and URR values. The ASM has good potential for clinical application, particularly for patients in areas of low socioeconomic status.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.